BeiGene’s Brukinsa Set To Take On Imbruvica With CLL Approval

 
• By Joseph Haas
  
BeiGene's Brukinsa adds US indication for chronic lymphocytic leukemia • Source: Shutterstock

More from New Products

More from Scrip